Dejan Bojanic - Concepedia

Author

Dejan Bojanic

University of Tennessee Health Science Center

Also Known As

D Bojanic, D. Bojanic, DEJAN BOJANIC, Dejan Bojanic

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

University of Tennessee Health Science Center Millennium Engineering and Integration (United States)University of Leicester Novartis (United States)University of Glasgow

About

Dejan Bojanic is an author at University of Tennessee Health Science Center specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	507
2	Health Sciences	3	3	167
3	Business	1	1	48
4	Engineering	1	1	14
5	Management	1	1	48

Dejan Bojanic

Publications

735

Citations

H-Index

Page 1

	Year	Citations
A Novel Membrane Potential-Sensitive Fluorescent Dye Improves Cell-Based Assays for Ion Channels Deborah F. Baxter, Martin L. Kirk, Amy F. Garcia, SLAS DISCOVERY	2002	144
Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni Miles D. Houslay, Dejan Bojanic, Andrew Wilson Biochemical Journal Gtpase ActivityMolecular BiologyInflammationThrombosisHuman Platelets	1986	135
Thrombin, unlike vasopressin, appears to stimulate two distinct guanine nucleotide regulatory proteins in human platelets Miles D. Houslay, Dejan Bojanic, Debra J. Gawler, Biochemical Journal ImmunologyMolecular BiologyThrombin-stimulated GtpasePertussis ToxinInflammation	1986	67
Atypical characteristics of the beta-adrenoceptor mediating cyclic AMP generation and lipolysis in the rat adipocyte. Dejan Bojanic, Johanna Jansen, Stefan R. Nahorski, PubMed Pa2 ValuesMetabolic SyndromeAdrenal GlandNeuroendocrine MechanismFenoterol-stimulated Lipolysis	1985	63
Which aspects of HTS are empirically correlated with downstream success? Andreas Bender, Dejan Bojanic, John Davies, PubMed Pharmaceutical ResearchHit IdentificationProductivityMedicinal ChemistryHts Quality	2008	48
Evaluation of Fluorescence- and Mass Spectrometry–Based CYP Inhibition Assays for Use in Drug Discovery Leslie Bell, Shari Bickford, Phong Hung Nguyen, SLAS DISCOVERY	2008	45
The combinatorial synthesis of a 30,752-compound library: discovery of SAR around the endothelin antagonist, FR-139,317 N.K. Terrett, Dejan Bojanic, David Brown, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryBiochemistryEndothelin AntagonistNatural Sciences	1995	44
Identification and subclassification of rat adipocyte β-adrenoceptors using Dejan Bojanic, Stefan R. Nahorski European Journal of Pharmacology Metabolic SyndromeMolecular PharmacologyMedicinePhysiologyNeuroendocrine Mechanism	1983	37
Handbook of Drug Screening Dejan Bojanic Drug Discovery Today PharmacologyDrug TestingDrug TestDrug MonitoringDrug Screening	2001	37
Imidazo[2′-3′-:6,5]dipyrido[3,2-b:2′,3′-e]-1,4-diazepines: non-nucleoside HIV-1 reverse transcriptase inhibitors with greater enzyme affinity than nevirapine Nicholas T. Terrett, Dejan Bojanic, James Merson, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineNatural SciencesAntiviral Drug DevelopmentAntiviral Therapy	1992	29

Page 1